Cargando…

Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study

AIMS/HYPOTHESIS: We studied the association of plasma ascorbic acid with the risk of developing islet autoimmunity and type 1 diabetes and examined whether SNPs in vitamin C transport genes modify these associations. Furthermore, we aimed to determine whether the SNPs themselves are associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattila, Markus, Erlund, Iris, Lee, Hye-Seung, Niinistö, Sari, Uusitalo, Ulla, Andrén Aronsson, Carin, Hummel, Sandra, Parikh, Hemang, Rich, Stephen S., Hagopian, William, Toppari, Jorma, Lernmark, Åke, Ziegler, Anette G., Rewers, Marian, Krischer, Jeffrey P., Norris, Jill M., Virtanen, Suvi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946743/
https://www.ncbi.nlm.nih.gov/pubmed/31728565
http://dx.doi.org/10.1007/s00125-019-05028-z
_version_ 1783485426817826816
author Mattila, Markus
Erlund, Iris
Lee, Hye-Seung
Niinistö, Sari
Uusitalo, Ulla
Andrén Aronsson, Carin
Hummel, Sandra
Parikh, Hemang
Rich, Stephen S.
Hagopian, William
Toppari, Jorma
Lernmark, Åke
Ziegler, Anette G.
Rewers, Marian
Krischer, Jeffrey P.
Norris, Jill M.
Virtanen, Suvi M.
author_facet Mattila, Markus
Erlund, Iris
Lee, Hye-Seung
Niinistö, Sari
Uusitalo, Ulla
Andrén Aronsson, Carin
Hummel, Sandra
Parikh, Hemang
Rich, Stephen S.
Hagopian, William
Toppari, Jorma
Lernmark, Åke
Ziegler, Anette G.
Rewers, Marian
Krischer, Jeffrey P.
Norris, Jill M.
Virtanen, Suvi M.
author_sort Mattila, Markus
collection PubMed
description AIMS/HYPOTHESIS: We studied the association of plasma ascorbic acid with the risk of developing islet autoimmunity and type 1 diabetes and examined whether SNPs in vitamin C transport genes modify these associations. Furthermore, we aimed to determine whether the SNPs themselves are associated with the risk of islet autoimmunity or type 1 diabetes. METHODS: We used a risk set sampled nested case–control design within an ongoing international multicentre observational study: The Environmental Determinants of Diabetes in the Young (TEDDY). The TEDDY study followed children with increased genetic risk from birth to endpoints of islet autoantibodies (350 cases, 974 controls) and type 1 diabetes (102 cases, 282 controls) in six clinical centres. Control participants were matched for family history of type 1 diabetes, clinical centre and sex. Plasma ascorbic acid concentration was measured at ages 6 and 12 months and then annually up to age 6 years. SNPs in vitamin C transport genes were genotyped using the ImmunoChip custom microarray. Comparisons were adjusted for HLA genotypes and for background population stratification. RESULTS: Childhood plasma ascorbic acid (mean ± SD 10.76 ± 3.54 mg/l in controls) was inversely associated with islet autoimmunity risk (adjusted OR 0.96 [95% CI 0.92, 0.99] per +1 mg/l), particularly islet autoimmunity, starting with insulin autoantibodies (OR 0.94 [95% CI 0.88, 0.99]), but not with type 1 diabetes risk (OR 0.93 [95% Cl 0.86, 1.02]). The SLC2A2 rs5400 SNP was associated with increased risk of type 1 diabetes (OR 1.77 [95% CI 1.12, 2.80]), independent of plasma ascorbic acid (OR 0.92 [95% CI 0.84, 1.00]). CONCLUSIONS/INTERPRETATION: Higher plasma ascorbic acid levels may protect against islet autoimmunity in children genetically at risk for type 1 diabetes. Further studies are warranted to confirm these findings. DATA AVAILABILITY: The datasets generated and analysed during the current study will be made available in the NIDDK Central Repository at https://www.niddkrepository.org/studies/teddy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-05028-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-6946743
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-69467432020-01-21 Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study Mattila, Markus Erlund, Iris Lee, Hye-Seung Niinistö, Sari Uusitalo, Ulla Andrén Aronsson, Carin Hummel, Sandra Parikh, Hemang Rich, Stephen S. Hagopian, William Toppari, Jorma Lernmark, Åke Ziegler, Anette G. Rewers, Marian Krischer, Jeffrey P. Norris, Jill M. Virtanen, Suvi M. Diabetologia Article AIMS/HYPOTHESIS: We studied the association of plasma ascorbic acid with the risk of developing islet autoimmunity and type 1 diabetes and examined whether SNPs in vitamin C transport genes modify these associations. Furthermore, we aimed to determine whether the SNPs themselves are associated with the risk of islet autoimmunity or type 1 diabetes. METHODS: We used a risk set sampled nested case–control design within an ongoing international multicentre observational study: The Environmental Determinants of Diabetes in the Young (TEDDY). The TEDDY study followed children with increased genetic risk from birth to endpoints of islet autoantibodies (350 cases, 974 controls) and type 1 diabetes (102 cases, 282 controls) in six clinical centres. Control participants were matched for family history of type 1 diabetes, clinical centre and sex. Plasma ascorbic acid concentration was measured at ages 6 and 12 months and then annually up to age 6 years. SNPs in vitamin C transport genes were genotyped using the ImmunoChip custom microarray. Comparisons were adjusted for HLA genotypes and for background population stratification. RESULTS: Childhood plasma ascorbic acid (mean ± SD 10.76 ± 3.54 mg/l in controls) was inversely associated with islet autoimmunity risk (adjusted OR 0.96 [95% CI 0.92, 0.99] per +1 mg/l), particularly islet autoimmunity, starting with insulin autoantibodies (OR 0.94 [95% CI 0.88, 0.99]), but not with type 1 diabetes risk (OR 0.93 [95% Cl 0.86, 1.02]). The SLC2A2 rs5400 SNP was associated with increased risk of type 1 diabetes (OR 1.77 [95% CI 1.12, 2.80]), independent of plasma ascorbic acid (OR 0.92 [95% CI 0.84, 1.00]). CONCLUSIONS/INTERPRETATION: Higher plasma ascorbic acid levels may protect against islet autoimmunity in children genetically at risk for type 1 diabetes. Further studies are warranted to confirm these findings. DATA AVAILABILITY: The datasets generated and analysed during the current study will be made available in the NIDDK Central Repository at https://www.niddkrepository.org/studies/teddy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-019-05028-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2019-11-14 2020 /pmc/articles/PMC6946743/ /pubmed/31728565 http://dx.doi.org/10.1007/s00125-019-05028-z Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Mattila, Markus
Erlund, Iris
Lee, Hye-Seung
Niinistö, Sari
Uusitalo, Ulla
Andrén Aronsson, Carin
Hummel, Sandra
Parikh, Hemang
Rich, Stephen S.
Hagopian, William
Toppari, Jorma
Lernmark, Åke
Ziegler, Anette G.
Rewers, Marian
Krischer, Jeffrey P.
Norris, Jill M.
Virtanen, Suvi M.
Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
title Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
title_full Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
title_fullStr Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
title_full_unstemmed Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
title_short Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study
title_sort plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the teddy study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946743/
https://www.ncbi.nlm.nih.gov/pubmed/31728565
http://dx.doi.org/10.1007/s00125-019-05028-z
work_keys_str_mv AT mattilamarkus plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT erlundiris plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT leehyeseung plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT niinistosari plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT uusitaloulla plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT andrenaronssoncarin plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT hummelsandra plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT parikhhemang plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT richstephens plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT hagopianwilliam plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT topparijorma plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT lernmarkake plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT ziegleranetteg plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT rewersmarian plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT krischerjeffreyp plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT norrisjillm plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT virtanensuvim plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy
AT plasmaascorbicacidandtheriskofisletautoimmunityandtype1diabetestheteddystudy